About
APITBIO is a biotechnology company developing antibody-based precision medicines and new antibody therapeutics. It was founded by experts in antibody development across industry, academia, research institutes, and hospitals, and is based in South Korea.
Services
Antibody Library
Maintains a proprietary synthetic antibody library with more than 20 billion diverse fully human monoclonal antibodies for antibody discovery.
Antibody Discovery
Uses a synthetic antibody library to screen and discover highly specific antibodies against target antigens.
Antibody Engineering
Converts Fab sequences into full-length IgG using one-vector or two-vector systems and optimizes IgG expression.
Antibody Optimization
Performs antibody optimization, including affinity maturation, to develop antibodies with improved efficacy and manufacturability.
Antibody Production, Purification, and Analysis
Produces antibodies for rodent and primate preclinical toxicity studies and provides in-house culture, purification, and analysis systems.
Bispecific Antibody Platform
Creates symmetric and asymmetric bispecific antibodies and can apply Fc engineering to adjust ADCC activity.
Capabilities
- Assays and studies
- Antibodies
- Cell therapy
- ADCs
- Bispecifics
- Antibody screening
- Affinity maturation
5 more
- Purification
- Analysis
- Antibody discovery
- Antibody engineering
- Production
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- Cell therapy
- Species and models
- Non-human primate
Details
- Based in
- Songpa-gu, South Korea